As part of GlaxoSmithKline's ($GSK) post-bribery-scandal efforts to clean up its marketing act, it has laid off workers whose business expenses didn't quite add up. But unfairly so, according to a trio of plaintiffs: They're suing for so-called "illegal dismissal," demanding compensation for their time at the drugmaker and reimbursement for bribes their managers allegedly instructed them to pay. Story